HSDT vs. ECOR

Last updated Apr 1, 2026

Compare and contrast key facts about Helius Medical Technologies, Inc. (HSDT) and electroCore, Inc. (ECOR).

Performance

HSDT vs. ECOR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Helius Medical Technologies, Inc. (HSDT) and electroCore, Inc. (ECOR). The values are adjusted to include any dividend payments, if applicable.

HSDT vs. ECOR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
HSDT Helius Medical Technologies, Inc.	-40.14%	-99.43%	-91.66%	-47.61%	-94.09%	-60.63%	-61.18%	-89.41%	-22.64%
ECOR electroCore, Inc.	34.45%	-72.33%	172.35%	54.54%	-55.92%	-62.66%	-1.89%	-74.60%	-68.46%

Fundamentals

EPS HSDT : -$4.55 ECOR : $0.00
PS Ratio HSDT : 2.59 ECOR : 1.05
Total Revenue (TTM) HSDT : $6.02M ECOR : $32.03M
Gross Profit (TTM) HSDT : $5.52M ECOR : $27.79M
EBITDA (TTM) HSDT : -$243.84M ECOR : $28.00K

Returns By Period

In the year-to-date period, HSDT achieves a -40.14% return, which is significantly lower than ECOR's 34.45% return.

HSDT

• 1D: -6.99%
• 1M: -7.49%
• YTD: -40.14%
• 6M: -88.38%
• 1Y: -99.42%
• 3Y*: -94.34%
• 5Y*: -92.37%
• 10Y*: -73.53%

ECOR

• 1D: 6.91%
• 1M: -20.45%
• YTD: 34.45%
• 6M: 21.82%
• 1Y: -9.87%
• 3Y*: 3.11%
• 5Y*: -27.59%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HSDT vs. ECOR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HSDT

HSDT Risk / Return Rank: 9
HSDT Sharpe Ratio Rank: 21
HSDT Sortino Ratio Rank: 1
HSDT Omega Ratio Rank: 2
HSDT Calmar Ratio Rank: 1
HSDT Martin Ratio Rank: 21

ECOR

ECOR Risk / Return Rank: 39
ECOR Sharpe Ratio Rank: 36
ECOR Sortino Ratio Rank: 42
ECOR Omega Ratio Rank: 41
ECOR Calmar Ratio Rank: 37
ECOR Martin Ratio Rank: 38

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HSDT vs. ECOR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Helius Medical Technologies, Inc. (HSDT) and electroCore, Inc. (ECOR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HSDT	ECOR	Difference
Sharpe ratio Return per unit of total volatility	-0.47	-0.11	-0.36
Sortino ratio Return per unit of downside risk	-2.25	0.49	-2.74
Omega ratio Gain probability vs. loss probability	0.71	1.06	-0.35
Calmar ratio Return relative to maximum drawdown	-1.00	-0.14	-0.86
Martin ratio Return relative to average drawdown	-1.11	-0.22	-0.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HSDT vs. ECOR - Sharpe Ratio Comparison

The current HSDT Sharpe Ratio is -0.47, which is lower than the ECOR Sharpe Ratio of -0.11. The chart below compares the historical Sharpe Ratios of HSDT and ECOR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HSDT	ECOR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.47	-0.11	-0.36
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.59	-0.32	-0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.37	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.38	-0.31	-0.07

Correlation

The correlation between HSDT and ECOR is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HSDT vs. ECOR - Dividend Comparison

Neither HSDT nor ECOR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

HSDT vs. ECOR - Drawdown Comparison

The maximum HSDT drawdown since its inception was -100.00%, roughly equal to the maximum ECOR drawdown of -98.95%. Use the drawdown chart below to compare losses from any high point for HSDT and ECOR.

Drawdown Indicators

	HSDT	ECOR	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-98.95%	-1.05%
Max Drawdown (1Y) Largest decline over 1 year	-99.47%	-45.99%	-53.48%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-89.88%	-10.12%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	—	—
Current Drawdown Current decline from peak	-100.00%	-97.97%	-2.03%
Average Drawdown Average peak-to-trough decline	-72.97%	-90.47%	+17.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	89.49%	29.52%	+59.97%

Volatility

HSDT vs. ECOR - Volatility Comparison

Helius Medical Technologies, Inc. (HSDT) has a higher volatility of 26.58% compared to electroCore, Inc. (ECOR) at 23.18%. This indicates that HSDT's price experiences larger fluctuations and is considered to be riskier than ECOR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HSDT	ECOR	Difference
Volatility (1M) Calculated over the trailing 1-month period	26.58%	23.18%	+3.40%
Volatility (6M) Calculated over the trailing 6-month period	96.11%	54.92%	+41.19%
Volatility (1Y) Calculated over the trailing 1-year period	212.62%	89.52%	+123.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	155.80%	87.44%	+68.36%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	200.11%	129.36%	+70.75%

Financials